Skip to content
Screener

Aura Biosciences, Inc. AURA Net Interest Income (After Provisions)

Net Interest Income (After Provisions) at other companies

Amalgamated Financial Corp. logo
Amalgamated Financial Corp.AMAL
$66.67M-4.7%
FB Financial logo
FB FinancialFBK
$142.94M+35.7%
Banner Corporation logo
Banner CorporationBANR
$150.97M+9.4%
STE
STELSTEL
$103.43M+8.2%
Federal Agricultural Mortgage logo
Federal Agricultural MortgageAGM
$97.09M+8.8%
Axos Financial logo
Axos FinancialAX
$265.26M+1.6%

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$826.46M+87.8%
Enterprise value$758.65M+118%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseAfterProvisionForLoanLoss.

The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216808
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Total operating expenses34,86629,035
Total operating loss(34,866)(29,035)
Other income (expense):
Interest income, including amortization and accretion income1,1901,594
Other income (expense)2(24)
Total other income1,1921,570
Loss before income taxes(33,674)(27,465)
Income tax provision, net(11)(18)

Item 1. Financial Statements.

FAQ

What is Aura Biosciences, Inc.'s net interest income (after provisions)?
Aura Biosciences, Inc. (AURA) reported net interest income (after provisions) of $1.19M in Q1 2026.
How has Aura Biosciences, Inc.'s net interest income (after provisions) changed year-over-year?
Aura Biosciences, Inc.'s net interest income (after provisions) decreased by 25.3% year-over-year, from $1.59M to $1.19M.
What is the long-term trend for Aura Biosciences, Inc.'s net interest income (after provisions)?
Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s net interest income (after provisions) has grown at a 375.2% compound annual growth rate (CAGR), from $13K to $6.63M.
What does net interest income (after provisions) mean?
The difference between interest income earned on cash and investment holdings and interest expenses incurred on debt obligations, adjusted for any provisions for credit losses. For a clinical-stage biotechnology company, this reflects the yield generated from treasury management of capital raised. It serves as a non-operating indicator of the company's ability to generate supplemental income from its liquid assets.

Ask your AI about Aura Biosciences, Inc.'s net interest income (after provisions).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude